Ocular Therapeutix (OCUL) Shareholder's Equity (2013 - 2026)
Ocular Therapeutix (OCUL) Shareholder's Equity (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Ocular Therapeutix |
2.12 Bn |
2.12 Bn |
9.46 Mn |
581.57 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
581.57 Mn |
| Dec 31, 2025 |
654.31 Mn |
| Sep 30, 2025 |
258.23 Mn |
| Jun 30, 2025 |
305.92 Mn |
| Mar 31, 2025 |
265.93 Mn |
| Dec 31, 2024 |
315.34 Mn |
| Sep 30, 2024 |
352.02 Mn |
| Jun 30, 2024 |
377.70 Mn |
| Mar 31, 2024 |
407.98 Mn |
| Dec 31, 2023 |
91.13 Mn |
| Sep 30, 2023 |
7.85 Mn |
| Jun 30, 2023 |
3.09 Mn |
| Mar 31, 2023 |
9.71 Mn |
| Dec 31, 2022 |
35.38 Mn |
| Sep 30, 2022 |
46.23 Mn |
| Jun 30, 2022 |
65.80 Mn |
| Mar 31, 2022 |
79.80 Mn |
| Dec 31, 2021 |
88.00 Mn |
| Sep 30, 2021 |
87.34 Mn |
| Jun 30, 2021 |
80.25 Mn |
